One of the first observations connecting AT inflammation to insulin resistance and obesity dates from studies on tumor necrosis factor (TNF)-α and efficacy of anti-TNF-α treatment in obese rodents [57]. This evidence concerns the gene TNF and obesity due to melanocortin 4 receptor deficiency.